Transpharmation Ltd.
07348226
Healthy
- 2 outstanding charges (-4)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 23/01/2012
CONSULTANT
BRITISH · UNITED KINGDOM · Age 54
Also on 1 other board
Persons with Significant Control
Former PSCs
Mr Mark Steven Duxon
Ceased 03/12/2021
Vivocore Inc.
Ceased 01/12/2021
Mr Joseph Araujo
Ceased 30/07/2024
Charges2 outstanding
NATIONAL BANK OF CANADA AS THE PLEDGEE (AS DEFINED IN THE INSTRUMENT EVIDENCING THE CHARGE ACCO
NATIONAL BANK OF CANADA (THE LENDER)
CompanyRankvs 254+ SIC 74909 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£4.5M
Balance sheet strength
Cash
£616k
Cash in the bank
Net Current Assets
£4.5M
Working capital
Current Assets
£5.6M
Current Liabilities
£1.1M
Fixed Assets
£5k
Debtors
£5.0M
Tax at Year End
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 5.06 | -£2.1M |
| 2023 | 6.69 | +£4.2M |
| 2021 | 4.92 | -£562k |
| 2020 | 6.44 | +£776k |
| 2019 | 9.70 | +£723k |
| 2018 | 6.98 | — |
Derived from filed accounts. Not audited figures.